The Oncology Institute of Hope and Innovation announced the promotions of Dr. Daniel Virnich to President and Dr. Matt Miller to Chief Operating Officer, effective March 15. As President, Dr. Virnich will oversee the Operations, Clinical, Compliance, Marketing, Physician Dispensary, and Human Resources functions at TOI. Since joining TOI in 2020 as Chief Operating Officer, Dr. Virnich has played an instrumental role in launching new service lines, improving patient satisfaction, and expanding the organization into new markets.

Prior to joining TOI, Dr. Virnich served as President of the Florida market at DaVita Medical Group, and Chief Medical Officer at TeamHealth Acute Care Services. Since joining TOI in 2020, Dr. Miller has focused on tangible improvements to TOI's operations that have had a meaningful impact on the experience of patients, physicians, and payor partners. Under his leadership, TOI has improved the reliability, efficiency, and transparency of centralized teams, and implemented new tools and infrastructure in preparation for TOI's rapid growth.

As Chief Operating Officer, Dr. Miller will oversee all field and central operations nationally for TOI, as well as technology and new market implementation teams. Before joining TOI, Dr. Miller served as Senior Vice President of Clinical Strategy at Landmark Health, and before Landmark was part of the healthcare consulting practice at McKinsey & Company.